February 16, 2026 11:45 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Actor Rajpal Yadav granted interim bail in ₹9-crore cheque bounce case | Learn AI or become redundant: Microsoft India President issues stark message | India’s wholesale inflation rises to 1.81% in January as manufacturing prices surge | 'India at forefront of AI revolution': PM Modi welcomes world leaders to Delhi summit | Rs 5,000 to women ahead of Tamil Nadu polls! Vijay slams Stalin, says: ‘take the money, blow the whistle’ | Modi congratulates Tarique Rahman as BNP clinches majority in Bangladesh polls | Bangladesh Polls: Tarique Rahman-led BNP secures 'absolute majority' with 151 seats in historic comeback | BJP MP files notice to cancel Rahul Gandhi's Lok Sabha membership, seeks life-long ban | Arrested in the morning, out by evening: Tycoon’s son walks free in Lamborghini crash case | ‘Why should you denigrate a section of society?’: Supreme Court pulls up ‘Ghooskhor Pandat’ makers
Delhi-Covaxin

No Covaxin doses for 18-44 years in Delhi from tomorrow

| @indiablooms | May 13, 2021, at 05:21 am

New Delhi/IBNS: People between the age group of 18-44 years will not get Covaxin doses in Delhi from Thursday as there is no stock of the Bharat Biotech developed vaccine left in the national capital.

The government has urged the central government to ensure uninterrupted supplies of vaccines, adding that Covishield stocks will last nine days.

There are four days of Covaxin left to be administered on frontline workers and those above 45.

The shots are essential for those who received the first dose around four weeks ago.

Earlier, Delhi Deputy Chief Minister Manish Sisodia has hit out at the Centre's vaccine management saying that Covaxin manufacturer Bharat Biotech has refused to supply the vaccine to the national capital.

Sisodia said Bharat Biotech has refused to supply the doses citing directives from the government and limited availability.

"Once again I would say exporting 6.6 crore doses was biggest mistake. We are forced to shut down 100 Covaxin-vaccination sites in 17 schools due to no supply," he wrote.

Sisodia said Delhi has asked for the supply of 1.34 crore doses, equal doses of Bharat Biotech's Covaxin and Serum Institute of India’s Covishield, to vaccinate the 18-44 age group.

Delhi entered the fourth week of lockdown on Monday, with stricter restrictions this time including the shutdown of the metro.

The national capital reported 13,287 new coronavirus cases and 300 more fatalities on Wednesday, while the positivity rate came down to 17 per cent.

India is currently reeling under the second wave of COVID-19 infections with around 3.5 lakh cases and 4,000 deaths being reported daily.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.